Media Center

Assets intended for use by media professionals.

For general media inquiries only, please call +1 908-740-5633 or e-mail Media Relations. Members of the media seeking information on a specific topic may also contact the following individuals:

Kelley Dougherty

Title: Global Reputation, Branding and Digital Media
Office Phone: +1 267-305-3552
Email: kelley_dougherty@merck.com

Scott Wright

Title: Enterprise Social Media
Office Phone: +1 267-305-3581
Email: scott.wright@merck.com

Tracy Ogden

Title: Global Media Relations and Executive Communications
Office Phone: +1 908-740-1747
Email: tracy_ogden@merck.com

Pamela Eisele

Title: Product, Pipeline & Supply Media Relations
Office Phone: +1 267-305-3558
Email: pamela_eisele@merck.com

Claire Gillespie

Title: Corporate Media Relations
Office Phone: +1 267-305-0932
Email: claire.gillespie@merck.com

Doris Li

Title: Corporate Media Relations
Office Phone: +1 908-740-1903
Email: Doris.Li@merck.com

 

Additional Contacts

Consumers:

For consumer or patient-related questions, please contact your physician, pharmacist or other health care provider.

To report an adverse experience with a specific Merck product, please call the Merck National Service Center at +1 800-672-6372.

Health Care Professionals:

If you are a physician, pharmacist or other health care provider and have a question(s) or need information about a specific Merck product or service, please call the Merck National Service Center for Health Care Professionals at +1 866-448-7590.

For Stock Holders:

Tel: +1 800-522-9114
Monday-Friday, 7AM – 7 PM CST

For Institutional Investors and Analysts:

Tel: +1 908-423-5881
Monday-Friday, 8:30 AM – 4 PM ET

Merck Corporate

Photography

Keytruda

Kenneth C. Frazier

ISENTRESS HD

Company Snapshot

From developing new therapies that treat and prevent disease to helping people in need, we're committed to improving health and well-being around the world. Visit our About Us section.

 
COMPANY FACT SHEET

Everything you need to know about Merck.

PIPELINE

Our pipeline is continually evolving and is updated quarterly.

OUR LEADERSHIP

How we govern ourselves as a company is as important as anything else we do.

Join the Conversation

Connect with us on Facebook, Twitter, and LinkedIn to learn more about our corporate initiatives, including those in health and wellness, philanthropy and corporate responsibility.

Scott M. Wright, Social Media +1 267-305-3581 Scott.Wright@merck.com

Please read our social media guidelines.

#GastricCancer is also known as #StomachCancer…but what is it? https://t.co/QSS9bruySU-1 day 7 hours ago
Thank you to all the patients and physicians who participated in our clinical trials & made today’s news possible.… https://t.co/xRM6DoBXl8-1 day 8 hours ago
Dr. Roger Perlmutter on our latest #ImmunoOncology news. https://t.co/c6xwatrx5k-1 day 8 hours ago
Pleased to share our latest #ImmunoOncology news for #GastricCancer: https://t.co/20zwVOvOuV-1 day 8 hours ago
Melanoma survivor Mike Schmidt joins the Your Cancer Game Plan team to bring resources to the #melanoma community: https://t.co/OmcwkE2VHC-1 day 13 hours ago
Merck
Melanoma survivor, Mike Schmidt, joins the Your Cancer Game Plan team alongside Savor Health, CancerCare & 4 melanoma advocacy groups - Melanoma Research Foundation, Melanoma Research Alliance, AIM at Melanoma and Melanoma International Foundation. Find out more about the program expansion: b​i​t​.​l​y​/​2​h​d​4​c​P​4
Your Cancer Game Plan
merck.com
about 1 day 13 hours ago
Merck
Mike Schmidt is ready to hit it out of the park. He’ll be sharing his tips for staying healthy during the #melanoma journey when he takes over the @Merck Twitter page on 9/20. Be sure to follow @Merck on Twitter and visit b​i​t​.​l​y​/​2​v​K​Z​2​f​A to learn more about his #melanoma game plan.
about 4 days 8 hours ago
Merck
Excited to introduce Your Cancer Game Plan to the melanoma community with survivor, Mike Schmidt, CancerCare & 4 #melanoma advocacy groups - AIM at Melanoma, Melanoma Research Alliance, Melanoma International Foundation and Melanoma Research Foundation: b​i​t​.​l​y​/​2​w​L​r​w​r​2
about 4 days 16 hours ago